• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚背景下糖尿病相关足部疾病的检测、管理与预防

Detection, management, and prevention of diabetes-related foot disease in the Australian context.

作者信息

McNeil Scott, Waller Kate, Poy Lorenzo Yves S, Mateevici Olimpia C, Telianidis Stacey, Qi Sara, Churilov Irina, MacIsaac Richard J, Galligan Anna

机构信息

High Risk Foot Service, St Vincent's Hospital Melbourne, Fitzroy 3065, Victoria, Australia.

Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne, Fitzroy 3065, Victoria, Australia.

出版信息

World J Diabetes. 2023 Jul 15;14(7):942-957. doi: 10.4239/wjd.v14.i7.942.

DOI:10.4239/wjd.v14.i7.942
PMID:37547594
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10401446/
Abstract

Diabetes-related foot disease (DFD) is a widely feared complication among people who live with diabetes. In Australia and globally, rates of disability, cardio-vascular disease, lower extremity amputation, and mortality are significantly increased in patients with DFD. In order to understand and prevent these outcomes, we analyse the common pathogenetic processes of neuropathy, arterial disease, and infection. The review then summarises important management considerations through the interdisciplinary lens. Using Australian and international guidelines, we offer a stepwise, evidence-based practical approach to the care of patients with DFD.

摘要

糖尿病相关足部疾病(DFD)是糖尿病患者普遍惧怕的一种并发症。在澳大利亚乃至全球,DFD患者的残疾率、心血管疾病发生率、下肢截肢率及死亡率均显著升高。为了解并预防这些后果,我们分析了神经病变、动脉疾病及感染的常见发病机制。本综述随后从多学科角度总结了重要的管理考量因素。我们依据澳大利亚和国际指南,为DFD患者的护理提供了一种循序渐进、基于证据的实用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/10401446/166817782256/WJD-14-942-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/10401446/ff3dbd8030cf/WJD-14-942-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/10401446/166817782256/WJD-14-942-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/10401446/ff3dbd8030cf/WJD-14-942-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ab/10401446/166817782256/WJD-14-942-g002.jpg

相似文献

1
Detection, management, and prevention of diabetes-related foot disease in the Australian context.澳大利亚背景下糖尿病相关足部疾病的检测、管理与预防
World J Diabetes. 2023 Jul 15;14(7):942-957. doi: 10.4239/wjd.v14.i7.942.
2
Australian evidence-based guidelines for the prevention and management of diabetes-related foot disease: a guideline summary.澳大利亚糖尿病相关足部疾病预防与管理循证指南:指南摘要
Med J Aust. 2023 Nov 20;219(10):485-495. doi: 10.5694/mja2.52136. Epub 2023 Oct 23.
3
Diabetes-related foot disease in Australia: a systematic review of the prevalence and incidence of risk factors, disease and amputation in Australian populations.澳大利亚与糖尿病相关的足部疾病:对澳大利亚人群中风险因素、疾病和截肢的患病率和发生率的系统评价。
J Foot Ankle Res. 2021 Jan 19;14(1):8. doi: 10.1186/s13047-021-00447-x.
4
Diabetes-related foot disease: new insights with an antipodean focus.糖尿病相关足部疾病:以澳大拉西亚为中心的新见解。
J Endocrinol. 2023 May 2;257(3). doi: 10.1530/JOE-22-0238. Print 2023 Jun 1.
5
Guidelines development protocol and findings: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.指南制定方案和发现:2021 年澳大利亚糖尿病相关足部疾病循证指南的一部分。
J Foot Ankle Res. 2022 Apr 19;15(1):28. doi: 10.1186/s13047-022-00533-8.
6
Trends in diabetes-related foot disease hospitalizations and amputations in Australia, 2010 to 2019.2010年至2019年澳大利亚糖尿病相关足部疾病住院和截肢情况的趋势
Diabetes Res Clin Pract. 2022 Dec;194:110189. doi: 10.1016/j.diabres.2022.110189. Epub 2022 Nov 26.
7
Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century.全球范围内糖尿病相关足部疾病和截肢住院发病率的趋势:21 世纪国家发病率的综述。
Diabetologia. 2023 Feb;66(2):267-287. doi: 10.1007/s00125-022-05845-9. Epub 2022 Dec 13.
8
Australian guideline on prevention of foot ulceration: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.澳大利亚足部溃疡预防指南:2021 年澳大利亚糖尿病相关足部疾病循证指南的一部分。
J Foot Ankle Res. 2022 Jul 6;15(1):53. doi: 10.1186/s13047-022-00534-7.
9
Prevalence and Burden of Diabetes-Related Foot Disease in New South Wales, Australia: Evidence from the 45 and Up Study Survey Data Linked with Health Services Data.澳大利亚新南威尔士州糖尿病相关足部疾病的患病率和负担:来自 45 岁及以上研究调查数据与卫生服务数据关联的证据。
Int J Environ Res Public Health. 2021 Nov 2;18(21):11528. doi: 10.3390/ijerph182111528.
10
Prioritisation of diabetes-related footcare amongst primary care healthcare professionals.优先考虑基层医疗保健专业人员的糖尿病相关足部护理。
J Clin Nurs. 2020 Dec;29(23-24):4653-4673. doi: 10.1111/jocn.15506. Epub 2020 Oct 5.

引用本文的文献

1
Mesenchymal stem cells in wound healing: A bibliometric analysis as a powerful research tool.伤口愈合中的间充质干细胞:作为一种强大研究工具的文献计量分析
World J Stem Cells. 2024 Sep 26;16(9):827-831. doi: 10.4252/wjsc.v16.i9.827.

本文引用的文献

1
Novel Topical Esmolol Hydrochloride (Galnobax) for Diabetic Foot Wound: Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Parallel-Group Study.新型局部盐酸埃莫洛尔(Galnobax)治疗糖尿病足伤口:1/2 期、多中心、随机、双盲、安慰剂对照平行组研究。
Adv Wound Care (New Rochelle). 2023 Aug;12(8):429-439. doi: 10.1089/wound.2022.0093. Epub 2022 Nov 16.
2
Australian guideline on prevention of foot ulceration: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.澳大利亚足部溃疡预防指南:2021 年澳大利亚糖尿病相关足部疾病循证指南的一部分。
J Foot Ankle Res. 2022 Jul 6;15(1):53. doi: 10.1186/s13047-022-00534-7.
3
Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.
澳大利亚外周动脉疾病诊断和管理指南:2021 年澳大利亚糖尿病相关足部疾病循证指南的一部分。
J Foot Ankle Res. 2022 Jul 5;15(1):51. doi: 10.1186/s13047-022-00550-7.
4
Temporal trends in non-traumatic lower extremity amputations (LEAs) and their association with 12-month mortality in people with diabetes, 2004-2016.2004-2016 年糖尿病患者非创伤性下肢截肢术(LEAs)的时间趋势及其与 12 个月死亡率的关系。
J Diabetes Complications. 2022 Jul;36(7):108221. doi: 10.1016/j.jdiacomp.2022.108221. Epub 2022 Jun 3.
5
Australian guideline on management of diabetes-related foot infection: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.澳大利亚糖尿病相关足部感染管理指南:2021 年澳大利亚糖尿病相关足部疾病循证指南的一部分。
J Foot Ankle Res. 2022 Jun 9;15(1):47. doi: 10.1186/s13047-022-00545-4.
6
Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions.肾素-血管紧张素-醛固酮系统抑制剂、他汀类药物和β受体阻滞剂在伴有足部病变的糖尿病合并下肢严重缺血患者中的应用。
J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221101980. doi: 10.1177/10742484221101980.
7
Foot Osteomyelitis Location and Rates of Primary or Secondary Major Amputations in Patients With Diabetes.足部骨髓炎糖尿病患者的原发性或继发性主要截肢部位和发生率。
Foot Ankle Int. 2022 Jul;43(7):957-967. doi: 10.1177/10711007221088552. Epub 2022 May 18.
8
Australian guideline on offloading treatment for foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.澳大利亚足部溃疡减压治疗指南:2021 年澳大利亚糖尿病相关足部疾病循证指南的一部分。
J Foot Ankle Res. 2022 May 5;15(1):31. doi: 10.1186/s13047-022-00538-3.
9
Guidelines development protocol and findings: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.指南制定方案和发现:2021 年澳大利亚糖尿病相关足部疾病循证指南的一部分。
J Foot Ankle Res. 2022 Apr 19;15(1):28. doi: 10.1186/s13047-022-00533-8.
10
Frailty Is Associated with Impaired Diabetic Foot Ulcer Healing and All-Cause Re-Hospitalization.衰弱与糖尿病足溃疡愈合受损及全因再次住院相关。
J Nutr Health Aging. 2022;26(2):169-173. doi: 10.1007/s12603-022-1726-7.